BU-NOT-SET

CONTACT US
Science-led OSD reformulation
  • Drug product
  • Manufacturing
woman in lab
Case study
De-risking complex generic OSD development
  • Development
  • Drug product
woman in lab
Case study
Science-led OSD development
  • Development
  • Drug product
lady in lab with PPE
Insight
Advanced deformulation for complex generic development
  • Drug product
  • Manufacturing
three scientists in laboratory
White paper
How to turn development challenges into predictable outcomes
  • Development
  • Drug product
two scientists in laboratory
Webinar
Managing risk as high-potency manufacturing scales
  • Drug product
white powder
Insight
Safely scaling high potency API manufacturing
  • Drug product
api white powder
Insight
A predictive approach to complex OSD development
  • Development
  • Drug product
OSD development
eBook
Predictable development for uneventful manufacturing
  • Development
Development Services Recipharm
Video
Insight
  • Corporate
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
Insight
  • Manufacturing
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
Brochure
  • Corporate
Recipharm 25 years
Fact sheet
  • Drug substance
API range
Insight
  • Drug substance
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
Insight
  • Industry trends
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
Insight
  • Corporate
Women in leadership
Insight
  • Drug product
The state of the oral solid dose development and manufacturing market
Insight
  • Drug substance
Characterising APIs is Essential for Combo Drug Formulations